CMS 2028 HCBS Quality Measures Proposal: Tailwinds for Digital Health and Home Care Stocks

The Centers for Medicare & Medicaid Services (CMS) has officially launched a 30-day public comment period on its proposed 2028 Home and Community-Based Services (HCBS) Quality Measure Set, a pivotal step in implementing the HCBS Access Rule. Published in the Federal Register this week with comments due by May 28, 2026, the proposal outlines 26 quality measures—26 in total, comprising 23 mandatory and three voluntary ones—focused on critical areas like person-centered planning, community inclusion, personal safety, and freedom from abuse and neglect.[1][2] This development, announced on April 29, 2026, by industry groups such as AHCA/NCAL, signals a transformative shift for the $100 billion-plus HCBS sector, with direct implications for digital health companies, healthcare stocks, insurance providers, and broader policy dynamics.

Breaking Down the Proposed Measures

At the core of CMS's proposal are 23 mandatory measures, including composites for 'Choosing the Services That Matter to You,' 'Personal Safety & Respect,' and 'Transportation to Medical Appointments.' Additional mandatory metrics cover long-term services and supports (LTSS) comprehensive assessments, community inclusion, and protections against abuse.[1] Voluntary measures include reassessment post-inpatient discharge, fall prevention screening, and optional surveys like HCBS CAHPS or NCI tools. Data collection will target HCBS waiver participants via case managers or surveys, with state-level reporting mandated by 2028.[1][4]

This framework stems from the HCBS Access Rule, aimed at expanding access and quality in Medicaid-funded home care, which serves over 4 million Americans annually amid surging demand from aging demographics. Experts note the measures' emphasis on person-centered care will necessitate robust data infrastructure, rippling effects down to individual providers.[2][3]

Impact on Digital Health Companies: A Compliance-Driven Boom

Digital health firms stand to gain disproportionately from this regulatory push. The requirement for systematic data gathering—via surveys, assessments, and composites—elevates platforms specializing in HCBS workflow automation, telehealth integration, and analytics. Companies like CareVoyant, which offers consumer-directed services primers tailored to home care, are positioned to capitalize as providers seek tools for mandatory reporting.[3]

Consider the scale: HCBS spending under Medicaid exceeded $120 billion in FY 2025, per prior CMS data, with quality measures set to enforce standardized metrics. Digital solutions for real-time tracking of personal safety, transportation, and service choice will become indispensable. Firms with EHR interoperability, AI-driven risk scoring for falls or abuse, and mobile survey capabilities could see revenue acceleration. For instance, platforms enabling 'LTSS comprehensive assessment and update' measures will address the administrative burden, potentially trimming compliance costs by 20-30% based on analogous HIT adoption in acute care.

Market reaction has been muted thus far, given the forward-looking 2028 horizon, but forward P/E multiples for digital health leaders like Teladoc Health (TDOC) or Amwell (AMWL)—trading at 15-20x forward earnings—could compress favorably as HCBS tailwinds materialize. Smaller pure-plays in home health tech, such as those partnering with AHCA/NCAL members, may experience sharper upside, with 50%+ growth projections if adoption mirrors post-2022 telehealth mandates.

Healthcare Stocks: Home Care Providers in the Spotlight

Home care and HCBS providers face both challenges and opportunities. While the 23 mandatory measures impose reporting burdens, they incentivize high performers through potential reimbursement uplifts under value-based frameworks. Leaders like Amedisys (AMED) or LHC Group (now under Optum), with market caps around $3-5 billion, have historically outperformed during regulatory clarity phases, gaining 15-25% in the six months post-similar CMS rules.

The proposal's focus on state-level aggregation belies provider-level impacts, as experts highlight ripple effects: agencies must align operations with measures like 'freedom from abuse and neglect' to maintain waiver eligibility.[2] This favors scaled operators with digital maturity, potentially consolidating the fragmented $50 billion private-pay home care market. Smaller providers may consolidate, boosting M&A activity—a trend seen in 2025's 200+ deals totaling $10 billion.

Bullish case: HCBS enrollment, projected to hit 5 million by 2030, couples with quality incentives to drive 8-10% annual sector growth, outpacing the broader healthcare index (XLV, up 12% YTD 2026).

Insurance Providers: Navigating Risk and Opportunity

Managed care organizations (MCOs) and Medicaid insurers like UnitedHealth Group (UNH), Centene (CNC), and Molina (MOH) administer 70% of HCBS waivers. The measures enhance oversight, mitigating fraud risks—estimated at $5-10 billion annually—while tying capitation rates to quality scores. UNH's Optum Health, a top HCBS manager, could leverage its 1.5 million annual assessments to excel in composites, supporting its 18% EPS growth trajectory.

Insurers face modest near-term costs for system upgrades but long-term savings from preventive measures like fall screening, which reduce hospitalizations by 25% per peer studies. With Medicaid redeterminations complete, stable enrollment—50 million lives—positions MCOs for margin expansion. CNC, trading at 12x forward earnings, offers value amid HCBS upside, potentially adding 200-300 basis points to medical loss ratios through data-driven care.

Broader Healthcare Policy Context

This proposal aligns with Biden-era priorities but persists under any administration, given bipartisan support for HCBS expansion—$20 billion allocated via American Rescue Plan extensions. Public comments, open until May 28, allow stakeholders to influence burden and feasibility; AHCA/NCAL urges input by May 15.[1][6]

Policy tailwinds include Kennedy's recent Ways and Means testimony critiquing paid family caregivers, which could pivot funding toward formalized HCBS, amplifying measure impacts.[3] Nationally, HCBS waitlists exceed 700,000, pressuring states to comply for federal matching funds (up to 75%).

Market Outlook and Investment Implications

Short-term, expect volatility as comments shape final rules, but the trajectory favors innovation. Digital health ETFs (e.g., XHE) and home health proxies within IHI could rally 10-15% by year-end on adoption news. Insurers remain defensive holds, with UNH's 3% dividend yield anchoring portfolios.

Risks include implementation delays or burden overload, potentially curbing small-provider participation. Yet, with HCBS as 60% of Medicaid LTSS spend, structural demand endures. Investors should monitor Federal Register updates and Q2 earnings for compliance previews.

In summary, CMS's 2028 HCBS Quality Measure Set cements a quality-over-volume paradigm, propelling digital health innovators, rewarding efficient providers, and fortifying insurers. This regulatory clarity, rooted in April 29 announcements, underscores enduring bullishness in home-based care equities amid demographic inevitability.

Bullish Titan covers healthcare equities at BullishDaily, blending regulatory insight with market dynamics.